InvestorsHub Logo
Followers 19
Posts 3820
Boards Moderated 0
Alias Born 09/23/2014

Re: longtermgems post# 25559

Sunday, 09/27/2015 8:18:55 PM

Sunday, September 27, 2015 8:18:55 PM

Post# of 140474
LTG, one thanks for proving my point that you don't understand that if they sell Outside US it is still revenue (which will come in 2016 - see timeline). Also, you are completely wrong LTG on design and submission to FDA - Look up adaptive design during Early Feasbility testing and clinical trials - what I am 99% sure is that Titan and Ximedica have built this in to their submission process which allows for changes during the process. I am 99% sure that TRXC has not built this in to their submission process - evident by the fact that they were supposed to have FDA approval in 2015, which they won't probably due to a redesign (b/c they probably didn't have the foresight to apply adaptive design request) and now they go out and buy an intuitive knockoff

IMO, Titan is ahead of schedule. I'm willing to bet $14 (which was the price of TRXC stock a year ago and it went down to $2.50 on Friday after the announcement they purchased ALF ) that SPORT will have revenue before Surgibot.